Biogen has entered a definitive merger agreement with Apellis Pharmaceuticals, signaling a major strategic acquisition. This event will trigger significant spending and activity around post-merger integration, including consolidating IT systems, finance departments, and HR platforms.
Filing excerpt
Agreement and Plan of Merger, dated as of March 31, 2026, by and among Apellis Pharmaceuticals, Inc., Biogen Inc. and Aspen Purchaser Sub, Inc.
What this signalsIntegration work after a deal often opens needs for new systems and services.
Competitors
Competitors named
sec-10qacquisitionAnnouncedGet every 10-Q signal for Biogen and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Biogen this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/81a840cf-e778-43ed-b012-bbb3454c8737 returns this record as JSON. POST /v1/companies/enrich returns every signal for biogen.com.
{
"signal_id": "81a840cf-e778-43ed-b012-bbb3454c8737",
"signal_type": "sec-10q",
"signal_subtype": "acquisitionAnnounced",
"detected_at": "2026-05-05T08:48:21.256+00:00",
"company": {
"name": "Biogen",
"domain": "biogen.com"
},
"data": {
"detail": "Biogen has entered a definitive merger agreement with Apellis Pharmaceuticals, signaling a major strategic acquisition. This event will trigger significant spending and activity around post-merger integration, including consolidating IT systems, finance departments, and HR platforms.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Value of merger with Apellis Pharmaceuticals"
},
"summary": "Biogen to acquire Apellis Pharmaceuticals in deal announced March 31, 2026",
"excerpts": "Agreement and Plan of Merger, dated as of March 31, 2026, by and among Apellis Pharmaceuticals, Inc., Biogen Inc. and Aspen Purchaser Sub, Inc.",
"relevance": 0.95,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000045/biib-20260331.htm",
"filing_date": "2026-04-29",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Integration needs coming",
"signal_category": "strategic",
"competitors_mentioned": [
"Apellis Pharmaceuticals, Inc."
]
}
}
curl https://signals.autobound.ai/v1/signals/81a840cf-e778-43ed-b012-bbb3454c8737 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"biogen.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.